Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2023-2028)

1.4.2 East Asia Market States and Outlook (2023-2028)

1.4.3 Europe Market States and Outlook (2023-2028)

1.4.4 South Asia Market States and Outlook (2023-2028)

1.4.5 Southeast Asia Market States and Outlook (2023-2028)

1.4.6 Middle East Market States and Outlook (2023-2028)

1.4.7 Africa Market States and Outlook (2023-2028)

1.4.8 Oceania Market States and Outlook (2023-2028)

1.4.9 South America Market States and Outlook (2023-2028)

1.5 Global Montelukast Drug Market Size Analysis from 2023 to 2028

1.5.1 Global Montelukast Drug Market Size Analysis from 2023 to 2028 by Consumption Volume

1.5.2 Global Montelukast Drug Market Size Analysis from 2023 to 2028 by Value

1.5.3 Global Montelukast Drug Price Trends Analysis from 2023 to 2028

1.6 COVID-19 Outbreak: Montelukast Drug Industry Impact

Chapter 2 Global Montelukast Drug Competition by Types, Applications, and Top Regions and Countries

2.1 Global Montelukast Drug (Volume and Value) by Type

2.1.1 Global Montelukast Drug Consumption and Market Share by Type (2017-2022)

2.1.2 Global Montelukast Drug Revenue and Market Share by Type (2017-2022)

2.2 Global Montelukast Drug (Volume and Value) by Application

2.2.1 Global Montelukast Drug Consumption and Market Share by Application (2017-2022)

2.2.2 Global Montelukast Drug Revenue and Market Share by Application (2017-2022)

2.3 Global Montelukast Drug (Volume and Value) by Regions

2.3.1 Global Montelukast Drug Consumption and Market Share by Regions (2017-2022)

2.3.2 Global Montelukast Drug Revenue and Market Share by Regions (2017-2022)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2017-2022 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2017-2022 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global Montelukast Drug Sales, Consumption, Export, Import by Regions (2017-2022)

4.1 Global Montelukast Drug Consumption by Regions (2017-2022)

4.2 North America Montelukast Drug Sales, Consumption, Export, Import (2017-2022)

4.3 East Asia Montelukast Drug Sales, Consumption, Export, Import (2017-2022)

4.4 Europe Montelukast Drug Sales, Consumption, Export, Import (2017-2022)

4.5 South Asia Montelukast Drug Sales, Consumption, Export, Import (2017-2022)

4.6 Southeast Asia Montelukast Drug Sales, Consumption, Export, Import (2017-2022)

4.7 Middle East Montelukast Drug Sales, Consumption, Export, Import (2017-2022)

4.8 Africa Montelukast Drug Sales, Consumption, Export, Import (2017-2022)

4.9 Oceania Montelukast Drug Sales, Consumption, Export, Import (2017-2022)

4.10 South America Montelukast Drug Sales, Consumption, Export, Import (2017-2022)

Chapter 5 North America Montelukast Drug Market Analysis

5.1 North America Montelukast Drug Consumption and Value Analysis

5.1.1 North America Montelukast Drug Market Under COVID-19

5.2 North America Montelukast Drug Consumption Volume by Types

5.3 North America Montelukast Drug Consumption Structure by Application

5.4 North America Montelukast Drug Consumption by Top Countries

5.4.1 United States Montelukast Drug Consumption Volume from 2017 to 2022

5.4.2 Canada Montelukast Drug Consumption Volume from 2017 to 2022

5.4.3 Mexico Montelukast Drug Consumption Volume from 2017 to 2022

Chapter 6 East Asia Montelukast Drug Market Analysis

6.1 East Asia Montelukast Drug Consumption and Value Analysis

6.1.1 East Asia Montelukast Drug Market Under COVID-19

6.2 East Asia Montelukast Drug Consumption Volume by Types

6.3 East Asia Montelukast Drug Consumption Structure by Application

6.4 East Asia Montelukast Drug Consumption by Top Countries

6.4.1 China Montelukast Drug Consumption Volume from 2017 to 2022

6.4.2 Japan Montelukast Drug Consumption Volume from 2017 to 2022

6.4.3 South Korea Montelukast Drug Consumption Volume from 2017 to 2022

Chapter 7 Europe Montelukast Drug Market Analysis

7.1 Europe Montelukast Drug Consumption and Value Analysis

7.1.1 Europe Montelukast Drug Market Under COVID-19

7.2 Europe Montelukast Drug Consumption Volume by Types

7.3 Europe Montelukast Drug Consumption Structure by Application

7.4 Europe Montelukast Drug Consumption by Top Countries

7.4.1 Germany Montelukast Drug Consumption Volume from 2017 to 2022

7.4.2 UK Montelukast Drug Consumption Volume from 2017 to 2022

7.4.3 France Montelukast Drug Consumption Volume from 2017 to 2022

7.4.4 Italy Montelukast Drug Consumption Volume from 2017 to 2022

7.4.5 Russia Montelukast Drug Consumption Volume from 2017 to 2022

7.4.6 Spain Montelukast Drug Consumption Volume from 2017 to 2022

7.4.7 Netherlands Montelukast Drug Consumption Volume from 2017 to 2022

7.4.8 Switzerland Montelukast Drug Consumption Volume from 2017 to 2022

7.4.9 Poland Montelukast Drug Consumption Volume from 2017 to 2022

Chapter 8 South Asia Montelukast Drug Market Analysis

8.1 South Asia Montelukast Drug Consumption and Value Analysis

8.1.1 South Asia Montelukast Drug Market Under COVID-19

8.2 South Asia Montelukast Drug Consumption Volume by Types

8.3 South Asia Montelukast Drug Consumption Structure by Application

8.4 South Asia Montelukast Drug Consumption by Top Countries

8.4.1 India Montelukast Drug Consumption Volume from 2017 to 2022

8.4.2 Pakistan Montelukast Drug Consumption Volume from 2017 to 2022

8.4.3 Bangladesh Montelukast Drug Consumption Volume from 2017 to 2022

Chapter 9 Southeast Asia Montelukast Drug Market Analysis

9.1 Southeast Asia Montelukast Drug Consumption and Value Analysis

9.1.1 Southeast Asia Montelukast Drug Market Under COVID-19

9.2 Southeast Asia Montelukast Drug Consumption Volume by Types

9.3 Southeast Asia Montelukast Drug Consumption Structure by Application

9.4 Southeast Asia Montelukast Drug Consumption by Top Countries

9.4.1 Indonesia Montelukast Drug Consumption Volume from 2017 to 2022

9.4.2 Thailand Montelukast Drug Consumption Volume from 2017 to 2022

9.4.3 Singapore Montelukast Drug Consumption Volume from 2017 to 2022

9.4.4 Malaysia Montelukast Drug Consumption Volume from 2017 to 2022

9.4.5 Philippines Montelukast Drug Consumption Volume from 2017 to 2022

9.4.6 Vietnam Montelukast Drug Consumption Volume from 2017 to 2022

9.4.7 Myanmar Montelukast Drug Consumption Volume from 2017 to 2022

Chapter 10 Middle East Montelukast Drug Market Analysis

10.1 Middle East Montelukast Drug Consumption and Value Analysis

10.1.1 Middle East Montelukast Drug Market Under COVID-19

10.2 Middle East Montelukast Drug Consumption Volume by Types

10.3 Middle East Montelukast Drug Consumption Structure by Application

10.4 Middle East Montelukast Drug Consumption by Top Countries

10.4.1 Turkey Montelukast Drug Consumption Volume from 2017 to 2022

10.4.2 Saudi Arabia Montelukast Drug Consumption Volume from 2017 to 2022

10.4.3 Iran Montelukast Drug Consumption Volume from 2017 to 2022

10.4.4 United Arab Emirates Montelukast Drug Consumption Volume from 2017 to 2022

10.4.5 Israel Montelukast Drug Consumption Volume from 2017 to 2022

10.4.6 Iraq Montelukast Drug Consumption Volume from 2017 to 2022

10.4.7 Qatar Montelukast Drug Consumption Volume from 2017 to 2022

10.4.8 Kuwait Montelukast Drug Consumption Volume from 2017 to 2022

10.4.9 Oman Montelukast Drug Consumption Volume from 2017 to 2022

Chapter 11 Africa Montelukast Drug Market Analysis

11.1 Africa Montelukast Drug Consumption and Value Analysis

11.1.1 Africa Montelukast Drug Market Under COVID-19

11.2 Africa Montelukast Drug Consumption Volume by Types

11.3 Africa Montelukast Drug Consumption Structure by Application

11.4 Africa Montelukast Drug Consumption by Top Countries

11.4.1 Nigeria Montelukast Drug Consumption Volume from 2017 to 2022

11.4.2 South Africa Montelukast Drug Consumption Volume from 2017 to 2022

11.4.3 Egypt Montelukast Drug Consumption Volume from 2017 to 2022

11.4.4 Algeria Montelukast Drug Consumption Volume from 2017 to 2022

11.4.5 Morocco Montelukast Drug Consumption Volume from 2017 to 2022

Chapter 12 Oceania Montelukast Drug Market Analysis

12.1 Oceania Montelukast Drug Consumption and Value Analysis

12.2 Oceania Montelukast Drug Consumption Volume by Types

12.3 Oceania Montelukast Drug Consumption Structure by Application

12.4 Oceania Montelukast Drug Consumption by Top Countries

12.4.1 Australia Montelukast Drug Consumption Volume from 2017 to 2022

12.4.2 New Zealand Montelukast Drug Consumption Volume from 2017 to 2022

Chapter 13 South America Montelukast Drug Market Analysis

13.1 South America Montelukast Drug Consumption and Value Analysis

13.1.1 South America Montelukast Drug Market Under COVID-19

13.2 South America Montelukast Drug Consumption Volume by Types

13.3 South America Montelukast Drug Consumption Structure by Application

13.4 South America Montelukast Drug Consumption Volume by Major Countries

13.4.1 Brazil Montelukast Drug Consumption Volume from 2017 to 2022

13.4.2 Argentina Montelukast Drug Consumption Volume from 2017 to 2022

13.4.3 Columbia Montelukast Drug Consumption Volume from 2017 to 2022

13.4.4 Chile Montelukast Drug Consumption Volume from 2017 to 2022

13.4.5 Venezuela Montelukast Drug Consumption Volume from 2017 to 2022

13.4.6 Peru Montelukast Drug Consumption Volume from 2017 to 2022

13.4.7 Puerto Rico Montelukast Drug Consumption Volume from 2017 to 2022

13.4.8 Ecuador Montelukast Drug Consumption Volume from 2017 to 2022

Chapter 14 Company Profiles and Key Figures in Montelukast Drug Business

14.1 Merck & Co.

14.1.1 Merck & Co. Company Profile

14.1.2 Merck & Co. Montelukast Drug Product Specification

14.1.3 Merck & Co. Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.2 Teva

14.2.1 Teva Company Profile

14.2.2 Teva Montelukast Drug Product Specification

14.2.3 Teva Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.3 Mylan

14.3.1 Mylan Company Profile

14.3.2 Mylan Montelukast Drug Product Specification

14.3.3 Mylan Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.4 Glenmark Pharmaceuticals

14.4.1 Glenmark Pharmaceuticals Company Profile

14.4.2 Glenmark Pharmaceuticals Montelukast Drug Product Specification

14.4.3 Glenmark Pharmaceuticals Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.5 Hikma Group

14.5.1 Hikma Group Company Profile

14.5.2 Hikma Group Montelukast Drug Product Specification

14.5.3 Hikma Group Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.6 Sandoz

14.6.1 Sandoz Company Profile

14.6.2 Sandoz Montelukast Drug Product Specification

14.6.3 Sandoz Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.7 Torrent Pharmaceuticals

14.7.1 Torrent Pharmaceuticals Company Profile

14.7.2 Torrent Pharmaceuticals Montelukast Drug Product Specification

14.7.3 Torrent Pharmaceuticals Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.8 Lannett Company

14.8.1 Lannett Company Company Profile

14.8.2 Lannett Company Montelukast Drug Product Specification

14.8.3 Lannett Company Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.9 Apotex

14.9.1 Apotex Company Profile

14.9.2 Apotex Montelukast Drug Product Specification

14.9.3 Apotex Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.10 Dr. Reddys Laboratories

14.10.1 Dr. Reddys Laboratories Company Profile

14.10.2 Dr. Reddys Laboratories Montelukast Drug Product Specification

14.10.3 Dr. Reddys Laboratories Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.11 Aurobindo Pharma

14.11.1 Aurobindo Pharma Company Profile

14.11.2 Aurobindo Pharma Montelukast Drug Product Specification

14.11.3 Aurobindo Pharma Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.12 Accord Healthcare

14.12.1 Accord Healthcare Company Profile

14.12.2 Accord Healthcare Montelukast Drug Product Specification

14.12.3 Accord Healthcare Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.13 Hetero

14.13.1 Hetero Company Profile

14.13.2 Hetero Montelukast Drug Product Specification

14.13.3 Hetero Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.14 Unimark

14.14.1 Unimark Company Profile

14.14.2 Unimark Montelukast Drug Product Specification

14.14.3 Unimark Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.15 Ajanta Pharma

14.15.1 Ajanta Pharma Company Profile

14.15.2 Ajanta Pharma Montelukast Drug Product Specification

14.15.3 Ajanta Pharma Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.16 MACLEODS

14.16.1 MACLEODS Company Profile

14.16.2 MACLEODS Montelukast Drug Product Specification

14.16.3 MACLEODS Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.17 Jubilant Pharma

14.17.1 Jubilant Pharma Company Profile

14.17.2 Jubilant Pharma Montelukast Drug Product Specification

14.17.3 Jubilant Pharma Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.18 Unichem Laboratories

14.18.1 Unichem Laboratories Company Profile

14.18.2 Unichem Laboratories Montelukast Drug Product Specification

14.18.3 Unichem Laboratories Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.19 Amneal Pharmaceuticals

14.19.1 Amneal Pharmaceuticals Company Profile

14.19.2 Amneal Pharmaceuticals Montelukast Drug Product Specification

14.19.3 Amneal Pharmaceuticals Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.20 Shanghai Anbison Lab

14.20.1 Shanghai Anbison Lab Company Profile

14.20.2 Shanghai Anbison Lab Montelukast Drug Product Specification

14.20.3 Shanghai Anbison Lab Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.21 Perrigo

14.21.1 Perrigo Company Profile

14.21.2 Perrigo Montelukast Drug Product Specification

14.21.3 Perrigo Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.22 Cipla

14.22.1 Cipla Company Profile

14.22.2 Cipla Montelukast Drug Product Specification

14.22.3 Cipla Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.23 CSPC Ouyi Pharmaceutical

14.23.1 CSPC Ouyi Pharmaceutical Company Profile

14.23.2 CSPC Ouyi Pharmaceutical Montelukast Drug Product Specification

14.23.3 CSPC Ouyi Pharmaceutical Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)

Chapter 15 Global Montelukast Drug Market Forecast (2023-2028)

15.1 Global Montelukast Drug Consumption Volume, Revenue and Price Forecast (2023-2028)

15.1.1 Global Montelukast Drug Consumption Volume and Growth Rate Forecast (2023-2028)

15.1.2 Global Montelukast Drug Value and Growth Rate Forecast (2023-2028)

15.2 Global Montelukast Drug Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)

15.2.1 Global Montelukast Drug Consumption Volume and Growth Rate Forecast by Regions (2023-2028)

15.2.2 Global Montelukast Drug Value and Growth Rate Forecast by Regions (2023-2028)

15.2.3 North America Montelukast Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.4 East Asia Montelukast Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.5 Europe Montelukast Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.6 South Asia Montelukast Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.7 Southeast Asia Montelukast Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.8 Middle East Montelukast Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.9 Africa Montelukast Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.10 Oceania Montelukast Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.2.11 South America Montelukast Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)

15.3 Global Montelukast Drug Consumption Volume, Revenue and Price Forecast by Type (2023-2028)

15.3.1 Global Montelukast Drug Consumption Forecast by Type (2023-2028)

15.3.2 Global Montelukast Drug Revenue Forecast by Type (2023-2028)

15.3.3 Global Montelukast Drug Price Forecast by Type (2023-2028)

15.4 Global Montelukast Drug Consumption Volume Forecast by Application (2023-2028)

15.5 Montelukast Drug Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology